INS and metabolic syndrome: Concerning the fasting insulin levels, they displayed a statistically significant reduction in obese and MetS individuals (k = 5, 1.19 (95% CI [0.14, 2.23]), p = 0.03 and k = 2, 2.27 (95% CI [1.04, 3.51]), p = 0.0003, respectively).